DOI:
10.1055/s-00035037
Methods of Information in Medicine
LinksClose Window
References
Williamson MP, Elder PA, Shaw ME, Devlin J, Knowles MA.
P16 (CDKN2) is a major deletion target at 9p21 in bladder cancer.
Hum Mol Genet 1995;
4: 1569-1577.
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.